SCHEMBL7698454

SCHEMBL7698454

c1ccc(SCc2nc3cc4ccccc4cc3nc2CSc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.45
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.41
POLB P06746 2/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
LMNA P02545 1/20 0.40
KMT2A Q03164 2/20 0.40
NISCH Q9Y2I1 1/20 0.39
ELANE P08246 1/20 0.38
MEN1 O00255 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7697719 0.86 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C9
SCHEMBL7694096 0.86 NPC1 (0.50) NQO2NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL7689877 0.83 SMN1; SMN2 (0.43) NQO2NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL7695589 0.83 APP (0.46) NQO2NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL7697050 0.83 TDP1 (0.44) NQO2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7697161 0.83 MAOA (0.43) NQO2RAB9AL3MBTL1MAPT
SCHEMBL7695424 0.80 CYP1A2 (0.42) NQO2NPC1RAB9ACYP1A2CYP3A4
SCHEMBL24115709 0.76 NQO2 (0.49) NQO2NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL7697058 0.75 RAB9A (0.50) NQO2NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL7698500 0.75 SOD1 (0.44) NQO2NPC1RAB9ASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed